Abstract 2534: Underlying mechanism of response to neddylation inhibition in a subset of glioblastoma
Abstract
Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults with a 5-year survival rate of ~3%. The ubiquitin/proteasome system maintains intracellular homeostasis via degradation of unwanted proteins. Bortezomib is a first-in-class, non-specific proteasome inhibitor exploiting this system, although it has poor penetration across the blood brain barrier, and its lack of specificity is accompanied by adverse...
Paper Details
Title
Abstract 2534: Underlying mechanism of response to neddylation inhibition in a subset of glioblastoma
Published Date
Jul 1, 2021
Journal
Volume
81
Issue
13_Supplement
Pages
2534 - 2534
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History